Breaking News Instant updates and real-time market news.

MS

Morgan Stanley

$45.94

-0.06 (-0.13%)

, HIBB

Hibbett Sports

$12.00

0.25 (2.13%)

16:16
08/25/17
08/25
16:16
08/25/17
16:16

Morgan Stanley reports 5.1% passive stake in Hibbett Sports

MS

Morgan Stanley

$45.94

-0.06 (-0.13%)

HIBB

Hibbett Sports

$12.00

0.25 (2.13%)

  • 11

    Sep

  • 18

    Sep

MS Morgan Stanley
$45.94

-0.06 (-0.13%)

08/09/17
WELS
08/09/17
INITIATION
Target $48
WELS
Market Perform
Morgan Stanley resumed with a Market Perform at Wells Fargo
Wells Fargo analyst Mike Mayo resumed coverage of Morgan Stanley with a Market Perform rating and $48 price target.
08/09/17
WELS
08/09/17
INITIATION
Target $265
WELS
Outperform
Goldman Sachs resumed with an Outperform at Wells Fargo
Wells Fargo analyst Mike Mayo resumed coverage of Goldman Sachs (GS) with an Outperform rating and $265 price target. The analyst prefers Goldman over Morgan Stanley (MS), saying the bank has about "twice as fast" organic revenue growth for more than 20 years, and "much faster" earnings growth over 15 years. Mayo named Citi (C) his top pick among the Large-Cap banks.
07/24/17
UBSW
07/24/17
DOWNGRADE
Target $230
UBSW
Neutral
Goldman Sachs downgraded to Neutral from Buy at UBS
UBS analyst Brennan Hawken downgraded Goldman Sachs (GS) to Neutral and cut his price target for the shares to $230 from $255. The bank closed Friday down $2.12 to $220.18. The market seems to be pricing in an inflection in Goldman's trading revenue despite the recent weakness, suggesting a recovery is needed to justify 2018 consensus estimates, Hawken tells investors in a research note. The analyst sees better opportunities for investors, such as Morgan Stanley (MS), as he has "limited confidence" in a revenue recovery at Goldman.
06/28/17
FBCO
06/28/17
NO CHANGE
Target $47
FBCO
Neutral
Morgan Stanley estimates lowered at Credit Suisse
Credit Suisse analyst Susan Roth Katzke lowered her estimates for Morgan Stanley to reflect the current low volume/low volatility trading environment. She maintains a Neutral rating and $47 price target on the stock.
HIBB Hibbett Sports
$12.00

0.25 (2.13%)

08/18/17
BARD
08/18/17
NO CHANGE
Target $10
BARD
Neutral
Hibbett Sports price target lowered to $10 from $15 at Baird
Baird analyst Peter Benedict lowered his price target for Hibbett Sports to $10 after the company's Q2 comps missed expectations. While an FY17 earnings guidance cut was expected, the magnitude was more severe on continued top-line weakness and even more pronounced margin pressure, Benedict tells investors in a post-earnings research note. He maintains a Neutral rating on Hibbett.
08/01/17
FBCO
08/01/17
NO CHANGE
Target $52
FBCO
Neutral
Foot Locker price target lowered to $52 from $66 at Credit Suisse
Credit Suisse analyst Christian Buss lowered his price target for Foot Locker (FL) to $52 from $66 given increasing industry headwinds and following disappointing commentary by peers Finish Line (FINL) and Hibbett Sports (HIBB). The analyst believes the best-in-class execution by Foot Locker may no longer be enough. He reiterates a Neutral rating on Foot Locker's shares.
07/25/17
FBCO
07/25/17
NO CHANGE
Target $14
FBCO
Underperform
Hibbett Sports price target lowered to $14 from $24 at Credit Suisse
Credit Suisse analyst Seth Sigman lowered his price target for Hibbett Sports to $14 from $24 after the company preannounced weaker Q2 results, dragged down by comps, related expense deleverage and much weaker gross margins. The analyst adds that results reflect weak demand, growing online competition along with elevated investment requirements as the company launches its first transactional website. He reiterates an Underperform rating on the shares.
07/25/17
ADAM
07/25/17
NO CHANGE
Target $14
ADAM
Hold
Hibbett Sports price target lowered to $14 from $22 at Canaccord
Canccord analyst Camilo Lyon lowered his price target on Hibbett Sports to $14 from $22 following the company's pre-announcement of "stunningly poor" results. The analyst noted the company expects Q2 comps to be down 10% along with significant gross margin pressure. The weakness was mainly due to a footwear miss led by decelerating in basketball and running, said Lyon, who maintained his Hold rating on Hibbett shares.

TODAY'S FREE FLY STORIES

SPX

S&P 500

$0.00

(0.00%)

08:00
09/24/18
09/24
08:00
09/24/18
08:00
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

08:00
09/24/18
09/24
08:00
09/24/18
08:00
Recommendations
Apple analyst commentary  »

Carrier discounts for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

FIVE

Five Below

$125.30

-1.21 (-0.96%)

08:00
09/24/18
09/24
08:00
09/24/18
08:00
Recommendations
Five Below analyst commentary  »

Five Below target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$48.28

0.99 (2.09%)

07:59
09/24/18
09/24
07:59
09/24/18
07:59
Recommendations
Foot Locker analyst commentary  »

Foot Locker fundamentals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

TIF

Tiffany

$126.63

-0.43 (-0.34%)

07:59
09/24/18
09/24
07:59
09/24/18
07:59
Conference/Events
Tiffany management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

BILI

Bilibili

$12.47

-0.93 (-6.94%)

07:58
09/24/18
09/24
07:58
09/24/18
07:58
Downgrade
Bilibili rating change  »

Morgan Stanley downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIC

Select Interior Concepts

$10.11

-0.89 (-8.09%)

07:58
09/24/18
09/24
07:58
09/24/18
07:58
Conference/Events
Select Interior Concepts management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

IVZ

Invesco

$24.31

-0.105 (-0.43%)

07:57
09/24/18
09/24
07:57
09/24/18
07:57
Recommendations
Invesco analyst commentary  »

Invesco investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VCTR

Victory Capital

$9.05

0.27 (3.08%)

07:56
09/24/18
09/24
07:56
09/24/18
07:56
Conference/Events
Victory Capital to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 09

    Oct

  • 10

    Oct

MCFT

MCBC Holdings

$36.88

-0.33 (-0.89%)

07:55
09/24/18
09/24
07:55
09/24/18
07:55
Recommendations
MCBC Holdings analyst commentary  »

MCBC Holdings price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAL

Delta Air Lines

$59.61

1.48 (2.55%)

, LUV

Southwest

$63.77

1.26 (2.02%)

07:55
09/24/18
09/24
07:55
09/24/18
07:55
Periodicals
U.S. airlines score win as Congress drops 'reasonable fee' rule, Reuters reports »

The U.S. airline industry…

DAL

Delta Air Lines

$59.61

1.48 (2.55%)

LUV

Southwest

$63.77

1.26 (2.02%)

AAL

American Airlines

$43.59

1.7 (4.06%)

UAL

United Continental

$89.94

0.8 (0.90%)

JBLU

JetBlue

$19.89

-0.015 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 03

    Oct

  • 06

    Nov

  • 09

    Nov

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

07:55
09/24/18
09/24
07:55
09/24/18
07:55
Conference/Events
Nightstar Therapeutics to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 03

    Oct

XON

Intrexon

$14.50

-0.035 (-0.24%)

07:54
09/24/18
09/24
07:54
09/24/18
07:54
Hot Stocks
Intrexon rises after announcing advances in production of medical cannabis »

Shares of Intrexon are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

07:53
09/24/18
09/24
07:53
09/24/18
07:53
Recommendations
Nightstar Therapeutics analyst commentary  »

Nightstar should trade…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 03

    Oct

UNFI

United Natural Foods

$31.02

-2.81 (-8.31%)

07:53
09/24/18
09/24
07:53
09/24/18
07:53
Upgrade
United Natural Foods rating change  »

United Natural Foods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

ARTNA

Artesian Resources

$35.86

0.07 (0.20%)

07:52
09/24/18
09/24
07:52
09/24/18
07:52
Hot Stocks
Artesian Resources expands board, appoints Michael Houghton »

Artesian Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$114.70

1.13 (0.99%)

07:51
09/24/18
09/24
07:51
09/24/18
07:51
Recommendations
Microsoft analyst commentary  »

Microsoft demand appears…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Nov

  • 03

    Mar

AZRX

AzurRx BioPharma

$2.53

0.04 (1.61%)

07:49
09/24/18
09/24
07:49
09/24/18
07:49
Hot Stocks
AzurRx BioPharma trial of MS1819-SD achieves primary, secondary endpoints »

AzurRx BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STAA

STAAR Surgical

$47.00

-0.9 (-1.88%)

07:49
09/24/18
09/24
07:49
09/24/18
07:49
Recommendations
STAAR Surgical analyst commentary  »

STAAR Surgical price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAIN

Hain Celestial

$26.25

-0.3 (-1.13%)

07:49
09/24/18
09/24
07:49
09/24/18
07:49
Recommendations
Hain Celestial analyst commentary  »

Jefferies boosts Hain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

, P

Pandora

$9.08

-0.31 (-3.30%)

07:48
09/24/18
09/24
07:48
09/24/18
07:48
Conference/Events
Sirius XM to host conference call »

Conference call to…

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

P

Pandora

$9.08

-0.31 (-3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

SCYX

Scynexis

$1.24

-0.04 (-3.13%)

07:46
09/24/18
09/24
07:46
09/24/18
07:46
Conference/Events
Scynexis management to meet with Maxim »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 01

    Oct

  • 27

    Nov

ROSE

Rosehill Resources

$8.20

-0.37 (-4.32%)

07:45
09/24/18
09/24
07:45
09/24/18
07:45
Conference/Events
Rosehill Resources management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

  • 28

    Sep

FLWS

1-800-Flowers.com

$11.90

0.6 (5.31%)

, FTD

FTD Companies

$2.77

-0.2303 (-7.68%)

07:45
09/24/18
09/24
07:45
09/24/18
07:45
Recommendations
1-800-Flowers.com, FTD Companies analyst commentary  »

1-800-Flowers.com being…

FLWS

1-800-Flowers.com

$11.90

0.6 (5.31%)

FTD

FTD Companies

$2.77

-0.2303 (-7.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

GDEN

Golden Entertainment

$23.29

-1.44 (-5.82%)

07:44
09/24/18
09/24
07:44
09/24/18
07:44
Recommendations
Golden Entertainment analyst commentary  »

Golden Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.